Morgan Stanley Analyst Initiates Equal Weight Rating On Personalis, Inc. (PSNL)

2 days ago 6

Fatima Gulzar

Tue, December 30, 2025 astatine 11:19 AM CST 2 min read

Personalis, Inc. (NASDAQ:PSNL) is among the 12 Best Genomics Stocks to Invest In.

Morgan Stanley Analyst Initiates Equal Weight Rating On Personalis, Inc. (PSNL)

Morgan Stanley Analyst Initiates Equal Weight Rating On Personalis, Inc. (PSNL)

The Fly reported connected December 2, 2025, that Morgan Stanley expert Kallum Titchmarsh took implicit sum of Personalis, Inc. (NASDAQ:PSNL) with an Equal Weight standing and a terms nonsubjective of $11, up from $9. The steadfast identified respective upcoming catalysts wrong its sum beingness starting successful 2026 and outlined increasing agleam spots crossed beingness subject instruments and diagnostics extremity markets. Morgan Stanley claimed that a valuation surge successful the 2nd fractional of the twelvemonth near manufacture multiples astatine just levels contempt favorable assemblage dynamics, prompting the slope to commencement sum with an In-Line manufacture stance.

In addition, Personalis, Inc. (NASDAQ:PSNL) lowered its full-year 2025 income forecast from $70 cardinal to $80 cardinal to a scope of $68 cardinal to $73 million. The projected income from pharmaceutical testing, services, and different clients has been reduced from $52 cardinal to $58 cardinal to $50 cardinal to $54 million.

In opposition to erstwhile projections of $15 cardinal to $16 million, gross from colonisation sequencing and endeavor clients was raised to $16.5 cardinal to $17 million. Clinical trial reimbursed gross has dropped from $3 cardinal to $6 cardinal to $1.5 cardinal to $2 million. Gross borderline estimation of 22% to 24%, nett nonaccomplishment of astir $85 million, and currency depletion of astir $75 cardinal were each reiterated by the business.

Personalis, Inc. (NASDAQ:PSNL) offers genomic sequencing and analytics technologies to assistance make tailored crab vaccines and different next-generation crab immunotherapies.

While we admit the imaginable of PSNL arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy successful 2025.

Disclosure. None


Read Entire Article